[HTML][HTML] DNA repair pathways and cisplatin resistance: an intimate relationship

CRR Rocha, MM Silva, A Quinet, JB Cabral-Neto… - Clinics, 2018 - SciELO Brasil
The main goal of chemotherapeutic drugs is to induce massive cell death in tumors.
Cisplatin is an antitumor drug widely used to treat several types of cancer. Despite its …

Cisplatin resistance and opportunities for precision medicine

L Amable - Pharmacological research, 2016 - Elsevier
Cisplatin is one of the most commonly used chemotherapy drugs, treating a wide range of
cancer types. Unfortunately, many cancers initially respond to platinum treatment but when …

Somatic ERCC2 Mutations Correlate with Cisplatin Sensitivity in Muscle-Invasive Urothelial Carcinoma

EM Van Allen, KW Mouw, P Kim, G Iyer, N Wagle… - Cancer discovery, 2014 - AACR
Cisplatin-based chemotherapy is the standard of care for patients with muscle-invasive
urothelial carcinoma. Pathologic downstaging to pT0/pTis after neoadjuvant cisplatin-based …

[HTML][HTML] Metformin overcomes resistance to cisplatin in triple-negative breast cancer (TNBC) cells by targeting RAD51

JO Lee, MJ Kang, WS Byun, SA Kim, IH Seo… - Breast Cancer …, 2019 - Springer
Background Chemotherapy is a standard therapeutic regimen to treat triple-negative breast
cancer (TNBC); however, chemotherapy alone does not result in significant improvement …

Formation and repair of interstrand cross-links in DNA

DM Noll, TMG Mason, PS Miller - Chemical reviews, 2006 - ACS Publications
Cellular DNA is susceptible to chemical modifications when exposed to various
environmental agents, chemotherapeutic agents, or endogenous agents produced by …

BRCA1 mRNA expression levels as an indicator of chemoresistance in lung cancer

M Taron, R Rosell, E Felip, P Mendez… - Human molecular …, 2004 - academic.oup.com
Lung cancer is the most common cancer, with dismal outcome. Treatment approaches,
including cisplatin-based chemotherapy and surgery, are currently based on the clinical …

Nucleotide excision repair: why is it not used to predict response to platinum-based chemotherapy?

NA Bowden - Cancer letters, 2014 - Elsevier
Platinum based therapy is one of the most effectively used chemotherapeutic treatments for
cancer. The mechanism of action of platinum compounds is to damage DNA and drive cells …

[HTML][HTML] Polymorphisms in DNA repair genes modulate survival in cisplatin/gemcitabine-treated non-small-cell lung cancer patients

R De las Peñas, M Sanchez-Ronco, V Alberola… - Annals of …, 2006 - Elsevier
Background: Impaired DNA repair capacity may favorably affect survival in
cisplatin/gemcitabine-treated non-small-cell lung cancer (NSCLC) patients. We investigated …

[HTML][HTML] The therapeutic potential of DNA damage repair pathways and genomic stability in lung cancer

JT Burgess, M Rose, D Boucher, J Plowman… - Frontiers in …, 2020 - frontiersin.org
Despite advances in our understanding of the molecular biology of the disease and
improved therapeutics, lung cancer remains the most common cause of cancer-related …

[HTML][HTML] High expression of long non-coding RNA SBF2-AS1 promotes proliferation in non-small cell lung cancer

J Lv, M Qiu, W Xia, C Liu, Y Xu, J Wang, X Leng… - Journal of Experimental …, 2016 - Springer
Background Recent evidence has proven that long noncoding RNAs (lncRNAs) play
important roles in cancer biology, while few lncRNAs have been characterized in NSCLC …